600628 Stock Overview
Owns and operates department stores in Shanghai, China. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Shanghai New World Co., Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥7.03 |
| 52 Week High | CN¥8.46 |
| 52 Week Low | CN¥5.30 |
| Beta | 0.060 |
| 11 Month Change | 6.68% |
| 3 Month Change | 26.90% |
| 1 Year Change | -4.87% |
| 33 Year Change | -6.02% |
| 5 Year Change | -29.49% |
| Change since IPO | 60.92% |
Recent News & Updates
Shareholder Returns
| 600628 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -1.4% | -1.3% | -3.4% |
| 1Y | -4.9% | -3.4% | 6.1% |
Return vs Industry: 600628 underperformed the CN Pharmaceuticals industry which returned -3.4% over the past year.
Return vs Market: 600628 underperformed the CN Market which returned 6.1% over the past year.
Price Volatility
| 600628 volatility | |
|---|---|
| 600628 Average Weekly Movement | 4.6% |
| Pharmaceuticals Industry Average Movement | 7.2% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.5% |
Stable Share Price: 600628 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 600628's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | 1,203 | Weimin Shen | www.newworld-china.com |
Shanghai New World Co., Ltd. owns and operates department stores in Shanghai, China. The company sells Chinese herbal medicines, Chinese patent medicines, western medicines, ginseng tonics, nutritional health products, and medical devices. It also operates hotel under the Radson brand.
Shanghai New World Co., Ltd Fundamentals Summary
| 600628 fundamental statistics | |
|---|---|
| Market cap | CN¥4.55b |
| Earnings (TTM) | CN¥45.48m |
| Revenue (TTM) | CN¥1.13b |
100.0x
P/E Ratio4.0x
P/S RatioIs 600628 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600628 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.13b |
| Cost of Revenue | CN¥672.96m |
| Gross Profit | CN¥461.15m |
| Other Expenses | CN¥415.66m |
| Earnings | CN¥45.48m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.07 |
| Gross Margin | 40.66% |
| Net Profit Margin | 4.01% |
| Debt/Equity Ratio | 13.0% |
How did 600628 perform over the long term?
See historical performance and comparison